September 30, 2012 (Press-News.org) A recent decision by the U.S. Judicial Panel on Multidistrict Litigation has decided to centralize 22 different lawsuits against Watson Pharmaceuticals in the Northern District of Illinois. These cases all stem from allegations that a product manufactured by Watson - a transdermal pain medication known as a fentanyl patch - is defective and has caused severe injuries and death.
Originally, Watson had hoped the Judicial Panel would have consolidated all fentanyl patch cases, including cases involving other manufacturers - such as ALZA Corp, Johnson & Johnson and Mylan Pharmaceuticals Inc - but the court decided that there were "insufficient commonalities among the allegations made against the different defendants" to justify consolidating all the cases.
Dangers Associated With Fentanyl Patches
Allegations surrounding the use of fentanyl patches are nothing new as warnings regarding their use have been around for years. In fact in 2005, and later in 2008, the Food and Drug Administration (FDA) issued public health advisories stating that many patients were using fentanyl patches more frequently than necessary and more at once than required - all leading to dangerously high levels of fentanyl in patients' blood.
High levels of fentanyl are dangerous given that fentanyl is a very strong and potent opioid pain medication, which should only be used to treat on-going moderate to severe pain. Moreover, according to the FDA, for patients who are not opioid-tolerant, even one fentanyl patch is strong enough to cause serious side-effects such as respiratory depression or even death.
To further add to the dangers of fentanyl patches, the FDA noted that doctors continue to inappropriately prescribe fentanyl patches to patients for various unintended uses - such as headaches or mild pain - despite warnings from the FDA.
Given how easy it is to overdose on fentanyl and the severe consequences of improper fentanyl patch use, doctors who continue to prescribe fentanyl patches for these "off-label" uses are placing the lives of their patients at risk - a continued practice that may also expose these doctors to civil liability and medical malpractice allegations for their actions.
If you or a loved one have been injured, or even killed, due to the use of a fentanyl patch, it is important to speak with an experienced personal injury attorney to see if you may have a personal injury, medical malpractice or wrongful death claim.
Article provided by Eisenberg Gilchrist & Cutt
Visit us at www.eisenbergandgilchrist.com
Fentanyl Patch Cases Consolidated in Single Federal Court
A recent Multidistrict Litigation opinion has decided to centralize 22 different lawsuits involving fentanyl patches, an transdermal pain medication, in the Northern District of Illinois.
2012-09-30
ELSE PRESS RELEASES FROM THIS DATE:
PA Highway Work Zones Pose Risks for Both Motorists and Workers
2012-09-30
During the summer months, it is a familiar sight -- orange cones, flashing lights, signs urging motorists on the highway to merge into one lane. While these work zones are necessary to maintain the safety of our infrastructure, they pose a risk both for workers on the job and drivers passing by. Consequently, it is imperative for Philadelphia drivers to exercise caution when traveling through work zones.
According to the Federal Highway Administration, accidents resulting in fatalities have decreased in recent years. In 2008, there were 716 fatal collisions in work zones ...
Ohio Bans Texting While Driving
2012-09-30
Distracted Driving: A Leading Cause of Serious Car Accidents
Texting while driving has become a serious safety concern, one that legislators and safety agencies are addressing nationwide. According to the Ohio Department of Public Safety/Bureau of Motor Vehicles, texting while driving takes your eyes off of the road for approximately five seconds. In this time, you are 23 times more likely to get into a car accident.
A recent survey by the AAA Foundation for Traffic Safety found that 35 percent of drivers admit to texting and driving. In 2009, this driving habit claimed ...
Jumeirah Zabeel Saray Launches X Factor Holiday Package in Dubai
2012-09-30
Jumeirah Zabeel Saray, the Ottoman inspired luxury resort located on Palm Jumeirah, has launched two 'As seen on X Factor' holiday packages prior to its debut on UK and Irish TV screens.
The hotel, which provided one of the locations for hit TV series The X Factor, hosted celebrity judge Nicole Scherzinger and her guest judge Ne-Yo alongside TV presenters Dermot O'Leary and Caroline Flack as they filmed one of four parts of the Judges' House scenes in Dubai.
The Royal and Deluxe holiday packages will give hotel guests the chance to replicate the experience of the ...
Barclaycard Makes Everyday Spending More Rewarding with Two New Reward Cards
2012-09-30
Barclaycard has announced the launch of its Barclaycard Cashback and Barclaycard Freedom Rewards cards, both designed to make it easier for customers to get value and rewards on their everyday spend, without changing the way they shop.
The Cashback card is built on simplicity, giving customers four times more cashback on their five biggest monthly purchases, with no tiers or thresholds. Customers earn 2% on their five biggest monthly purchases and 0.5% on everything else. All customers need to do is make fifteen purchases a month, of any amount to qualify for the 2% ...
"Dead Walk" Haunted Prison Experience Shakes Visitors to Their Core
2012-09-30
The Ohio State Reformatory in Mansfield, Ohio has gained a national reputation as one of the most haunted places in America, while also being an architectural and cultural treasure. Travelers come from around the globe to brave the historic reformatory's hair-raising, one-of-a-kind Haunted Prison Experience. Beyond the Haunted Prison Experience, six additional haunted sites are now available in and around Mansfield, making the city a dream destination for fans of the paranormal investigation, as well as visitors who just love a good scare. The prison and many of Mansfield's ...
Businesses Urged to Stock Up on Safety Supplies Ahead of Winter
2012-09-30
Are you looking to prepare your business for winter? If so, it's wise to stock up on safety supplies before the cold spell hits. This is the latest advice from whatishealthandsafety.co.uk and is designed to keep staff, visitors and general members of the public safe.
- The importance of winter safety products highlighted by website
- Snow shovels, snow ploughs and de-icing equipment deemed essential
- Companies advised to carry out a risk assessment ahead of winter
According to the site - which provides a wealth of safety information for both small and large organisations ...
Surrogacy India - Wyzax The Only Healthcare Corporate for Surrogacy in Delhi
2012-09-30
Wyzax Surrogacy Consultants (WSC) is a specialized surrogacy arm of Wyzax Corp., which is engaged in a vast range of healthcare activities like Pharmaceutical marketing, Biotechnological research and Medical Tourism.
WSC is The Only Healthcare Corporate in India which functions differently from the ART clinics because unlike the latter, we work on the US model, whereby, rather than carrying out IVF at our own centre, we offer the IPs the option of getting the IVF done at any of the world class ART clinics which are on our panel. We at WSC provides end to end surrogacy ...
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer
2012-09-29
Vienna, Austria, 29 September 2012 – Treatment with the drug sorafenib as a third or fourth line therapy does not result in improved overall survival among patients with advanced non-small cell lung cancer (NSCLC), according to findings released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. However, a post-hoc biomarker analysis of the trial data that was also presented suggests that patients with EGFR-mutant tumors may benefit.
Sorafenib is an oral inhibitor of several tyrosine protein kinases, which can be active in cancers. At the ...
Studies show drug combinations effective for melanoma
2012-09-29
Vienna, Austria, 29 September 2012 –- Promising new data on drug combinations to treat metastatic melanoma are presented at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
The phase I and II trials focus on combining drugs to slow the development of resistance to drugs that inhibit BRAF, a gene that is mutated in about half of melanomas. Earlier trials with drugs that target BRAF generated excitement for their ability to quickly shrink melanoma tumors in suitable patients. But for many patients the benefits proved short-lived, as the cancer ...
Studies show advances in gastrointestinal cancer treatments
2012-09-29
VIENNA, Austria, 29 September 2012 –- New trial data showing improvements in the treatment of esophageal and gastrointestinal cancers were released today at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Phase III, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy
The first phase III trial to address the need for second-line treatments in esophageal cancer shows that gefitinib improves important quality-of-life measures and extends progression-free survival, ...
LAST 30 PRESS RELEASES:
Norbert Holtkamp appointed director of Fermi National Accelerator Laboratory
New agentic AI platform accelerates advanced optics design
Biologists discover neurons use physical signals — not electricity — to stabilize communication
Researchers discover that a hormone can access the brain by hitchhiking
University of Oklahoma researcher awarded funding to pursue AI-powered material design
Exploring how the visual system recovers following injury
Support for parents with infants at pediatric check-ups leads to better reading and math skills in elementary school
Kids’ behavioral health is a growing share of family health costs
Day & night: Cancer disrupts the brain’s natural rhythm
COVID-19 vaccination significantly reduces risk to pregnant women and baby
The role of vaccination in maternal and perinatal outcomes associated with COVID-19 in pregnancy
Mayo Clinic smartwatch system helps parents shorten and defuse children's severe tantrums early
Behavioral health spending spikes to 40% of all children’s health expenditures, nearly doubling in a decade
Digital cognitive behavioral treatment for generalized anxiety disorder
Expenditures for pediatric behavioral health care over time and estimated family financial burden
Air conditioning in nursing homes and mortality during extreme heat
The Alps to lose a record number of glaciers in the next decade
What makes a good proton conductor?
New science reporting guide published for journalists in Bulgaria
New international study reveals major survival gaps among children with cancer
New science reporting guide published for journalists in Turkey
Scientists develop a smarter mRNA therapy that knows which cells to target
Neuroanatomy-informed brain–machine hybrid intelligence for robust acoustic target detection
Eight SwRI hydrogen projects funded by ENERGYWERX
The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Con
Fine particles in pollution are associated with early signs of autoimmune disease
Review article | Towards a Global Ground-Based Earth Observatory (GGBEO): Leveraging existing systems and networks
Penn and UMich create world’s smallest programmable, autonomous robots
Cleveland researchers launch first major study to address ‘hidden performance killer’ in athletes
To connect across politics, try saying what you oppose
[Press-News.org] Fentanyl Patch Cases Consolidated in Single Federal CourtA recent Multidistrict Litigation opinion has decided to centralize 22 different lawsuits involving fentanyl patches, an transdermal pain medication, in the Northern District of Illinois.